Invention Grant
- Patent Title: Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
- Patent Title (中): 哌嗪衍生物，其制备方法及其用于治疗胰岛素抵抗的用途
-
Application No.: US14128381Application Date: 2012-06-22
-
Publication No.: US09150523B2Publication Date: 2015-10-06
- Inventor: Gerard Moinet , Gabriel Baverel , Remi Nazaret , Bernard Ferrier
- Applicant: Gerard Moinet , Gabriel Baverel , Remi Nazaret , Bernard Ferrier
- Applicant Address: FR
- Assignee: METABOLYS
- Current Assignee: METABOLYS
- Current Assignee Address: FR
- Agency: Cantor Colburn LLP
- Priority: FR1155545 20110623
- International Application: PCT/EP2012/062143 WO 20120622
- International Announcement: WO2012/175707 WO 20121227
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D241/20 ; C07D213/74 ; C07D295/088 ; A61K31/495 ; A61K31/497 ; C07D295/096 ; A61K45/06
Abstract:
Disclosed herein are compounds and compositions useful in the treatment of pathologies associated with the insulin resistance syndrome (or syndrome X), in particular in the treatment of type 2 diabetes.
Public/Granted literature
Information query
IPC分类:
